Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Merck Sharp & Dohme LLC | 1,389 |
| 2 | AbbVie Inc | 1,246 |
| 3 | Procter and Gamble Co | 739 |
| 4 | Purdue Pharma LP | 630 |
| 5 | Genentech Inc | 510 |
| 6 | F Hoffmann La Roche AG | 482 |
| 7 | Takeda Pharmaceutical Co Ltd | 467 |
| 8 | Pfizer Inc | 463 |
| 9 | Amgen Inc | 362 |
| 10 | Ono Pharmaceutical Co Ltd | 358 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 42,888 |
| 2 | A61K | Medicinal preparations | 40,840 |
| 3 | C07D | Heterocyclic compounds | 19,361 |
| 4 | C07K | Peptides | 9,019 |
| 5 | Y02A | Climate change adaptation | 4,246 |
| 6 | C07C | Acyclic and carbocyclic compounds | 3,602 |
| 7 | C12N | Microorganisms, enzymes | 3,525 |
| 8 | G01N | Investigating / analysing materials | 3,099 |
| 9 | A61L | Sterilising / disinfecting materials | 2,749 |
| 10 | A61Q | Cosmetics, personal care | 2,377 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | 2000 | GD Searle LLC | 9 |
| Oxaprozin calcium salt | 1984 | John Wyeth and Brother Ltd | 7 |
| Oxaprozin calcium salt pharmaceutical compositions | 1985 | John Wyeth and Brother Ltd | 6 |
| Oxaprozin or closely related compound for the treatment and prevention of pruritus | 2006 | Astion Development A/S | 3 |
| Oxaprozin and preparation technology thereof | 2012 | SHANDONG KERNEL AND HALL PHARMACEUTICAL INDUSTRY CO., LTD. | 2 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Drug-Induced Adverse Reactions | 2 |
| 2 | Inflammatory mediators and NSAID effects | 2 |
| 3 | Porphyrin Metabolism and Disorders | 2 |
| 4 | Computational Drug Discovery Methods | 1 |
| 5 | Drug-Induced Hepatotoxicity and Protection | 1 |
| 6 | Musculoskeletal pain and rehabilitation | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Barry R. Walker | University of Pennsylvania | 8 |
| 2 | Francesca Maestrelli | University of Florence | 6 |
| 3 | Hans W. Ruelius | University of Pennsylvania | 6 |
| 4 | James Inglese | National Institutes of Health | 6 |
| 5 | Jerome A. Hubsher | Penn Center for AIDS Research | 5 |
| 6 | Ajit Jadhav | National Center for Advancing Translational Sciences | 4 |
| 7 | Anton Simeonov | National Center for Advancing Translational Sciences | 4 |
| 8 | Daniel Merk | Goethe University Frankfurt | 4 |
| 9 | Frank W. Janssen | Penn Center for AIDS Research | 4 |
| 10 | Matthew D. Hall | National Institutes of Health | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical structure of Oxaprozin?
Which pharmaceutical companies have been active in patenting inventions related to Oxaprozin?
What are some early patent examples for Oxaprozin formulations?
What research topics are associated with Oxaprozin in the scientific literature?
What is the patent classification landscape for compounds like Oxaprozin?